A Wall Street Journal feature this week on researchers' long-standing concerns about the consequences of patients talking about clinical trials online…

Having had a week to mull over the FDA's latest batch of social media guidance, some observers have concluded the agency is making a blunt statement to…

Authorities removed more than 19,000 ads on Facebook, Twitter and YouTube that promoted the illegal sale of medicines.

The steady flow of posts about adverse events on social media provide an interesting opportunity for the FDA to improve postmarketing safety surveillance. Yet…

While it is years now since clinical trial participants started talking about their experiences online, the industry is still searching for the best way to…

It is almost four years since Facebook passed 500 million users. And while the role of it and other social media in clinical trials has generated lots of media…

The account--elilillyco--has posted old photographs of Lilly's facilities and researchers alongside pictures of what its current staff are doing.

Pfizer CEO Ian Read has become the first pharma executive to contribute an article to LinkedIn's publishing platform.